Novel and potent catalytic approach that directly clears amyloid on the inside of neurons as well as reduces amyloid plaques with the potential to be superior to monoclonal antibodies and restore ...

Alzheimer's disease (AD) is a neurodegenerative disease that causes progressive memory loss and a significant decline in ...

Add Yahoo as a preferred source to see more of our stories on Google. In the latest research showing the benefits of staying active as you get older, exercise has been found to reduce the risk of ...

Co-pathology may speed brain changes in women ...

What happens when a promising therapy falls short? Medscape spoke with Jeffrey Cummings, MD, who led the EVOKE trials of the GLP-1 semaglutide for AD, about what the results mean — and what comes next ...

The final stages of Alzheimer’s disease represent one of the most challenging periods for families watching their loved ones navigate this devastating condition. Understanding the critical signs that ...

Alzheimer's-related brain changes progressed up to 20 times faster in women who also had abnormal levels of a ...

New panel expands coverage for Alzheimer's and Parkinson's diseases including 15 new biomarkers developed with support from The Michael J. Fox Foundation for Parkinson's Research (MJFF) and 12 assays ...

Don’t sleep on this troubling symptom of Alzheimer’s. Despite primarily affecting people over the age of 65, the most common ...

Rural Americans face higher Alzheimer's risk but often lack access to specialists and early diagnostic tools, prompting calls ...

Frontotemporal dementia (FTD), in particular, may be at play, and identifying ways to slow down its progression can help. In ...